Morning Analyst Calls Briefing for Friday, November 18, 2022 

Photo of Paul Ausick
By Paul Ausick Published
Morning Analyst Calls Briefing for Friday, November 18, 2022 

© gorodenkoff / iStock via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Domino’s Pizza (DPZ) upgraded to Buy from Neutral at Northcoast; tgt $460

> Pinnacle West (PNW) upgraded to Neutral from Sell at Guggenheim; tgt raised to $70

> Ross Stores (ROST) upgraded to Buy from Hold at Gordon Haskett; tgt $130

Downgrades:

> Chart Industries (GTLS) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $133

> Editas Medicine (EDIT) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $13

> Editas Medicine (EDIT) downgraded to Perform from Outperform at Oppenheimer; tgt lowered to $12

> HP Inc. (HPQ) downgraded to Neutral from Outperform at Credit Suisse

> RH (RH) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $270

Others:

> 4D Molecular Therapeutics (FDMT) initiated with a Buy at H.C. Wainwright; tgt $36

> Akili Inc. (AKLI) initiated with a Neutral at BofA Securities; tgt $2

> Amgen (AMGN) initiated with an Underperform at Credit Suisse; tgt $240

> Arcus Biosciences (RCUS) initiated with a Neutral at BofA Securities; tgt $33

> Bristol-Myers (BMY) initiated with a Neutral at Credit Suisse; tgt $78

> Conagra (CAG) upgraded to Buy from Neutral at UBS; tgt raised to $41

> CoStar Group (CSGP) resumed with a Buy at BofA Securities; tgt $100

> DraftKings (DKNG) initiated with an Overweight at Piper Sandler; tgt $21

> Dragonfly Energy (DFLI) initiated with a Buy at Chardan Capital Markets; tgt $15

> Eli Lilly (LLY) initiated with an Outperform at Credit Suisse; tgt $395

> Fulgent Genetics (FLGT) initiated with an Outperform at Raymond James; tgt $45

> Insmed (INSM) initiated with a Buy at BofA Securities; tgt $39

> Johnson & Johnson (JNJ) initiated with a Neutral at Credit Suisse; tgt $170

> Merck (MRK) initiated with an Outperform at Credit Suisse; tgt $120

> NeoGames (NGMS) initiated with an Underperform at BofA Securities; tgt $16

> Pfizer (PFE) initiated with an Outperform at Credit Suisse; tgt $55

> Precigen (PGEN) initiated with an Overweight at Cantor Fitzgerald; tgt $7

Research calls posted earlier this morning are available here.  

Contact [email protected] for any questions or corrections.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

ABNB Vol: 15,913,532
MCHP Vol: 19,139,274
PLTR Vol: 77,244,625
MRNA Vol: 6,820,582
AXON Vol: 1,591,869

Top Losing Stocks

TTD Vol: 133,458,224
CTRA Vol: 73,319,495
AKAM Vol: 8,143,961
ZTS Vol: 12,784,553
RMD Vol: 3,810,438